 |
| On the morning of the morning of the 27th, when the Pfizer vaccination for the treatment of Corona 19 patients began, medical staff are dispensing the Pfizer vaccine into syringes at a sterile workbench (Cleanbench) in the Central Vaccination Center at the National Central Medical Center in Jung-gu, Seoul. 2021.2.27/News1 © News1 Photo Sharing Foundation |
Vaccination against the novel coronavirus infection (Corona 19) will speed up from March.
This month, approximately 352,000 workers at high-risk medical institutions and 78,000 first responders to Corona 19 will be vaccinated. They are given the AstraZeneca (AZ) vaccine. Pfizer’s vaccination, targeting 54,910 people in the treatment hospital for COVID-19 patients, will also be expanded from the metropolitan area to the whole country.
According to the Corona 19 Vaccination Response Promotion Team on the 1st, it was found that the first dose of the Corona 19 vaccine for 2,322 people in Korea was made for two days from February 26 to 28 0:00. Of these, 22,22 people received the AstraZeneca vaccine, and 300 people received the Pfizer vaccine.
In terms of the vaccination rate, the AstraZeneca vaccine is about 6.9% based on the 280,980 people who are hospitalized and admitted to nursing facilities, nursing homes under the age of 65, and workers under the age of 65. Pfizer’s vaccine amounts to 0.5% of the 54,910 workers in the hospital treating COVID-19 patients.
As it is in the early days of vaccination, it is analyzed that many people have not yet received vaccination. However, the speed of vaccination is expected to increase in March as the number of inoculations and vaccination institutions increases. In the case of AstraZeneca vaccine, shipments of about 1.57 million doses (for 785,000 people) for February-March were completed by the 28th of last month.
Accordingly, on the 3rd, a list of about 352,000 workers at high-risk medical institutions and 78,000 first responders to Corona 19 will be confirmed for the AstraZeneca vaccination, and the public health center will begin vaccination guidance.
The AstraZeneca vaccine has begun on the 26th of last month for 280,480 people who are hospitalized and admitted to nursing facilities and nursing facilities under the age of 65.
Workers at high-risk medical institutions who will be vaccinated this month are senior general hospitals, general hospitals, and health care workers working in hospitals that are frequented by general severe patients. As there are many contacts with patients who are at high risk of corona19 infection, such as decreased immunity, it was selected as a priority vaccination target.
They will be given individual vaccinations in the hospital. Corona 19 paramedics or epidemiological investigators visit public health centers and receive vaccinations. The first vaccination of all of them will be completed in this month and the second vaccination will be conducted in May.
Pfizer vaccination will also be expanded from the metropolitan area to the whole country. In the case of Pfizer’s vaccine, priority supply came in Korea on the 27th of last month through an application for COVAX.
Immediately upon arrival in Korea, the vaccine is 64,000 dos at the Central Vaccination Center of the National Medical Center, and the area is 164,000 dos for Soonchunhyang University Cheonan Hospital, 19900 dos for Yangsan Pusan National University Hospital, 15,000 dos at Chosun University Hospital, 59,000 dos at Keimyung University Dongsan Hospital. Respectively.
However, vaccination is being performed only at the central vaccination center for workers in the treatment hospital for COVID-19 patients in the metropolitan area. Five local vaccination institutions observe cases of vaccination at the central vaccination center and start vaccination on the 3rd of this month.
In addition, medical institutions with more than 120 personnel in the hospital will receive Pfizer vaccines from the vaccination center and begin in-house vaccination from the 8th. Accordingly, the inoculation of 28,839 people in the metropolitan area and 24,890 people in the non-metropolitan area will be in full swing.
Meanwhile, a total of 112 adverse reactions after the vaccine vaccination reported in Korea until the previous day were recorded. By vaccine, there were 96 AstraZeneca vaccines and 1 Pfizer vaccine. Symptoms were mild cases such as headache, fever, nausea, and vomiting.